1-1 of 1
Michael Hawkins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Clinical Trials & Observations
Jeff Sharman, Michael Hawkins, Kathryn Kolibaba, Michael Boxer, Leonard Klein, Meihua Wu, Jing Hu, Steve Abella, Chris Yasenchak
Journal: Blood
Blood (2015) 125 (15): 2336–2343.
https://doi.org/10.1182/blood-2014-08-595934
Published: 2015
Includes: Supplemental data